Literature DB >> 24585564

Asymptomatic Leishmania infection: a new challenge for Leishmania control.

Om Prakash Singh1, Epco Hasker, David Sacks, Marleen Boelaert, Shyam Sundar.   

Abstract

Visceral leishmaniasis (VL) is a serious parasitic disease, causing high morbidity and mortality in the developing world. The pathogenesis of VL is complex, and the clinical presentation ranges from asymptomatic infection to severe and fatal disease. Despite a wealth of research on the full-blown "clinical VL" syndrome, asymptomatic leishmania infections remain poorly understood. Asymptomatic infection could present a major challenge for control programs if its infectiousness is confirmed. In this viewpoint, we highlight the crucial knowledge gaps as well as the obstacles in research on asymptomatic leishmanial infection. Research in this area is essential for the development of more-effective VL control strategies.

Entities:  

Keywords:  asymptomatic infection; immunity; visceral leishmaniasis

Mesh:

Year:  2014        PMID: 24585564      PMCID: PMC4001287          DOI: 10.1093/cid/ciu102

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  61 in total

Review 1.  Diagnosis of visceral leishmaniasis.

Authors:  Pankaj Srivastava; Anand Dayama; Sanjana Mehrotra; Shyam Sundar
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-11       Impact factor: 2.184

2.  IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani.

Authors:  Maira G R Pitta; Audrey Romano; Sandrine Cabantous; Sandrine Henri; Awad Hammad; Bouréma Kouriba; Laurent Argiro; Musa el Kheir; Bruno Bucheton; Charles Mary; Sayda Hassan El-Safi; Alain Dessein
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

3.  Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals.

Authors:  S P Singh; E Hasker; A Picado; K Gidwani; P Malaviya; R P Singh; M Boelaert; S Sundar
Journal:  Trop Med Int Health       Date:  2010-05-06       Impact factor: 2.622

4.  Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India.

Authors:  Roshan K Topno; Vidya N R Das; Alok Ranjan; Krishna Pandey; Dharmender Singh; Nawin Kumar; Niyamat A Siddiqui; Vijay P Singh; Shreekant Kesari; Narendra Kumar; Sanjeev Bimal; Annadurai Jeya Kumar; Chetram Meena; Ranjeet Kumar; Pradeep Das
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

5.  No evidence for association between SLC11A1 and visceral leishmaniasis in India.

Authors:  Sanjana Mehrotra; Joyce Oommen; Anshuman Mishra; Medhavi Sudharshan; Puja Tiwary; Sarra E Jamieson; Michaela Fakiola; Deepa Selvi Rani; Kumarasamy Thangaraj; Madhukar Rai; Shyam Sundar; Jenefer M Blackwell
Journal:  BMC Med Genet       Date:  2011-05-20       Impact factor: 2.103

6.  Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva.

Authors:  Meredith F Clements; Kamlesh Gidwani; Rajiv Kumar; Jitka Hostomska; Diwakar S Dinesh; Vijay Kumar; Pradeep Das; Ingrid Müller; Gordon Hamilton; Vera Volfova; Marleen Boelaert; Murari Das; Suman Rijal; Albert Picado; Petr Volf; Shyam Sundar; Clive R Davies; Matthew E Rogers
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

7.  The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India.

Authors:  M Boelaert; F Meheus; A Sanchez; S P Singh; V Vanlerberghe; A Picado; B Meessen; S Sundar
Journal:  Trop Med Int Health       Date:  2009-04-20       Impact factor: 2.622

8.  Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial.

Authors:  Albert Picado; Shri Prakash Singh; Suman Rijal; Shyam Sundar; Bart Ostyn; François Chappuis; Surendra Uranw; Kamlesh Gidwani; Basudha Khanal; Madhukar Rai; Ishwari Sharma Paudel; Murari Lal Das; Rajiv Kumar; Pankaj Srivastava; Jean Claude Dujardin; Veerle Vanlerberghe; Elisabeth Wreford Andersen; Clive Richard Davies; Marleen Boelaert
Journal:  BMJ       Date:  2010-12-29

9.  Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.

Authors:  Bart Ostyn; Kamlesh Gidwani; Basudha Khanal; Albert Picado; François Chappuis; Shri Prakash Singh; Suman Rijal; Shyam Sundar; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

10.  Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control.

Authors:  Anette Stauch; Ram Rup Sarkar; Albert Picado; Bart Ostyn; Shyam Sundar; Suman Rijal; Marleen Boelaert; Jean-Claude Dujardin; Hans-Peter Duerr
Journal:  PLoS Negl Trop Dis       Date:  2011-11-29
View more
  64 in total

1.  The sera from adult patients with suggestive signs of autoimmune diseases present antinuclear autoantibodies that cross-react with Leishmania infantum conserved proteins: crude Leishmania histone and Soluble Leishmania antigens [corrected].

Authors:  Sami Lakhal; Meriem Benabid; Ines Ben Sghaier; Jihen Bettaieb; Aïda Bouratbine; Yousr Galai
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 2.  Using models to provide rapid programme support for California's efforts to suppress Huanglongbing disease of citrus.

Authors:  Neil McRoberts; Sara Garcia Figuera; Sandra Olkowski; Brianna McGuire; Weiqi Luo; Drew Posny; Tim Gottwald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-08       Impact factor: 6.237

3.  Asymptomatic Visceral Leishmania infantum Infection in US Soldiers Deployed to Iraq.

Authors:  Rupal M Mody; Ines Lakhal-Naouar; Jeffrey E Sherwood; Nancy L Koles; Dutchabong Shaw; Daniel P Bigley; Edgie-Mark A Co; Nathanial K Copeland; Linda L Jagodzinski; Rami M Mukbel; Rebecca A Smiley; Robert C Duncan; Shaden Kamhawi; Selma M B Jeronimo; Robert F DeFraites; Naomi E Aronson
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

Review 4.  Advances toward Diagnostic Tools for Managing Zoonotic Visceral Leishmaniasis.

Authors:  Malcolm S Duthie; Aurore Lison; Orin Courtenay
Journal:  Trends Parasitol       Date:  2018-08-18

5.  Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.

Authors:  F Matthew Kuhlmann; John I Robinson; Gregory R Bluemling; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

6.  Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts.

Authors:  Michael A Mandell; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

7.  Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response.

Authors:  Erin A Brettmann; Jahangheer S Shaik; Haroun Zangger; Lon-Fye Lye; F Matthew Kuhlmann; Natalia S Akopyants; Dayna M Oschwald; Katherine L Owens; Suzanne M Hickerson; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-18       Impact factor: 11.205

Review 8.  Chemotherapeutics of visceral leishmaniasis: present and future developments.

Authors:  Shyam Sundar; Anup Singh
Journal:  Parasitology       Date:  2017-12-07       Impact factor: 3.234

Review 9.  Elimination of visceral leishmaniasis on the Indian subcontinent.

Authors:  Om Prakash Singh; Epco Hasker; Marleen Boelaert; Shyam Sundar
Journal:  Lancet Infect Dis       Date:  2016-09-28       Impact factor: 25.071

Review 10.  Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.

Authors:  Shyam Sundar; Om Prakash Singh; Jaya Chakravarty
Journal:  Expert Rev Anti Infect Ther       Date:  2018-10-10       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.